Transforming pharma R&D with a scientist-centric approach to AI & automation
pharmaphorum
JUNE 16, 2021
As biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new way of working. Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. Ensuring a future of Computer-Aided Biology. About the author.
Let's personalize your content